These data indicated that XDD might promote angiogenesis via upregulating the VEGF, bFGF, and CD34 protein expressions, which may be one of the mechanisms for inhibiting the cerebral ischemia-reperfusion injury. The gene discussed is FGF2; the disease is Cerebral ischemia.